Tag - EPRX

Eupraxia Pharmaceuticals (NASDAQ: EPRX; TSX: EPRX) has announced the appointment of Jeymi Tambiah, MB ChB, FRCS, MS, FAPCR, FFPM, as chief medical officer (CMO), and the retirement of the current CMO, Dr. Mark Kowalski...